Pacer Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,340
| Closed | -$335K | – | 3434 |
|
|
2025
Q1 | $335K | Sell |
8,340
-16,503
| -66% | -$663K | ﹤0.01% | 1593 |
|
|
2024
Q4 | $1.17M | Buy |
24,843
+690
| +3% | +$32.5K | ﹤0.01% | 1269 |
|
|
2024
Q3 | $1.28M | Buy |
24,153
+5,433
| +29% | +$287K | ﹤0.01% | 1200 |
|
|
2024
Q2 | $1.01M | Buy |
18,720
+3,271
| +21% | +$177K | ﹤0.01% | 1269 |
|
|
2024
Q1 | $1.08M | Buy |
+15,449
| New | +$1.08M | ﹤0.01% | 1180 |
|
|
2021
Q2 | – | Sell |
-3,417
| Closed | -$79K | – | 1446 |
|
|
2021
Q1 | $79K | Sell |
3,417
-2,214
| -39% | -$51.2K | ﹤0.01% | 1324 |
|
|
2020
Q4 | $117K | Buy |
5,631
+3,234
| +135% | +$67.2K | ﹤0.01% | 1339 |
|
|
2020
Q3 | $52K | Buy |
+2,397
| New | +$52K | ﹤0.01% | 1305 |
|
|
2018
Q4 | – | Sell |
-2,648
| Closed | -$26K | – | 668 |
|
|
2018
Q3 | $26K | Buy |
+2,648
| New | +$26K | ﹤0.01% | 1171 |
|
|
2018
Q1 | – | Sell |
-1,250
| Closed | -$10K | – | 1059 |
|
|
2017
Q4 | $10K | Buy |
+1,250
| New | +$10K | ﹤0.01% | 1143 |
|